Your browser doesn't support javascript.
loading
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis.
Loosli, Tom; Hossmann, Stefanie; Ingle, Suzanne M; Okhai, Hajra; Kusejko, Katharina; Mouton, Johannes; Bellecave, Pantxika; van Sighem, Ard; Stecher, Melanie; d'Arminio Monforte, Antonella; Gill, M John; Sabin, Caroline A; Maartens, Gary; Günthard, Huldrych F; Sterne, Jonathan A C; Lessells, Richard; Egger, Matthias; Kouyos, Roger D.
Afiliación
  • Loosli T; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Hossmann S; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Ingle SM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Okhai H; Institute for Global Health, University College London, London, UK.
  • Kusejko K; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Mouton J; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Bellecave P; Virology Laboratory, University Hospital Bordeaux, Bordeaux, France.
  • van Sighem A; Stichting HIV Monitoring, Amsterdam, Netherlands.
  • Stecher M; German Center for Infection Research (DZIF), Partner-Site Cologne-Bonn, Cologne, Germany; Department I of Internal Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), University of Milan, Milan, Italy.
  • Gill MJ; Southern Alberta Clinic, Calgary, AB, Canada; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Sabin CA; Institute for Global Health, University College London, London, UK.
  • Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Lessells R; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Egger M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town,
  • Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Lancet HIV ; 10(11): e733-e741, 2023 11.
Article en En | MEDLINE | ID: mdl-37832567
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH / Inhibidores de Integrasa VIH Límite: Humans Idioma: En Revista: Lancet HIV Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH / Inhibidores de Integrasa VIH Límite: Humans Idioma: En Revista: Lancet HIV Año: 2023 Tipo del documento: Article País de afiliación: Suiza